ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,546 | -13.0% | 650 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $15,568 | +27.3% | 650 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $12,233 | +18.2% | 650 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $10,348 | -5.9% | 650 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $11,000 | +22.2% | 650 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -43.8% | 650 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $16,000 | +6.7% | 650 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $15,000 | +36.4% | 650 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $11,000 | -31.2% | 650 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $16,000 | -5.9% | 650 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $17,000 | -51.4% | 650 | 0.0% | 0.01% | -54.5% |
| Q4 2020 | $35,000 | -98.3% | 650 | -96.3% | 0.01% | -98.7% |
| Q3 2020 | $2,025,000 | +6432.3% | 17,470 | +2587.7% | 0.85% | +6461.5% |
| Q2 2020 | $31,000 | +14.8% | 650 | 0.0% | 0.01% | -23.5% |
| Q1 2020 | $27,000 | -3.6% | 650 | 0.0% | 0.02% | +54.5% |
| Q4 2019 | $28,000 | +21.7% | 650 | 0.0% | 0.01% | -8.3% |
| Q3 2019 | $23,000 | +35.3% | 650 | 0.0% | 0.01% | +20.0% |
| Q2 2019 | $17,000 | 0.0% | 650 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $17,000 | +54.5% | 650 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $11,000 | -15.4% | 650 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $13,000 | +30.0% | 650 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $10,000 | -33.3% | 650 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $15,000 | -25.0% | 650 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $20,000 | -16.7% | 650 | 0.0% | 0.01% | -27.3% |
| Q3 2017 | $24,000 | +33.3% | 650 | 0.0% | 0.01% | +37.5% |
| Q2 2017 | $18,000 | -18.2% | 650 | 0.0% | 0.01% | -27.3% |
| Q1 2017 | $22,000 | +15.8% | 650 | 0.0% | 0.01% | +22.2% |
| Q4 2016 | $19,000 | -55.8% | 650 | -50.0% | 0.01% | -66.7% |
| Q3 2015 | $43,000 | +4.9% | 1,300 | 0.0% | 0.03% | +35.0% |
| Q4 2014 | $41,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |